Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder. - Wikidata - wikimedia - TriplyDB

Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder.

Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder.

http://www.wikidata.org/entity/Q48374137

about

Amphetamine, past and present--a pharmacological and clinical perspective A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults Update on optimal use of lisdexamfetamine in the treatment of ADHD.A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder A systematic review of the safety of lisdexamfetamine dimesylate.Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study.Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD.Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.Spontaneous coronary artery dissection in a 22-year-old man on lisdexamfetamine Treating attention-deficit/hyperactivity disorder in adults: focus on once-daily medications.Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial Attention deficit hyperactivity disorder subtypes and symptom response in adults treated with lisdexamfetamine dimesylate.Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate.Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder The use of lisdexamfetamine dimesylate for the treatment of ADHD.Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology.The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe.The safety of extended-release drug formulations for the treatment of ADHD.Lisdexamfetamine: A Review in ADHD in Adults.Adult ADHD: A new disease?A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK.Metabolism of the prodrug lisdexamfetamine dimesylate in human red blood cells from normal and sickle cell disease donors Participant-perceived quality of life in a long-term, open-label trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.Expert Opinion and Recommendations for the Management of Attention-Deficit/Hyperactivity Disorder in Correctional Facilities.Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder.Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine.The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder.Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate.Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.Triple-Bead Mixed Amphetamine Salts (SHP465) in Adults With ADHD: Results of a Phase 3, Double-Blind, Randomized, Forced-Dose Trial.A Long-Term, Open-Label, Safety Study of Triple-Bead Mixed Amphetamine Salts (SHP465) in Adults With ADHD.Six-year outcome in subjects diagnosed with attention-deficit/hyperactivity disorder as adults.A clinician's guide to ADHD treatment options.

P2860

Q22241826-BDD29FCB-A33F-43C9-A1E0-3B8690A8D97C Q24632726-712E8F0C-DE53-4BE1-97D5-C616CDC000D4 Q26750486-66380DCE-D158-4D11-8209-78EC4A774DE8 Q28246506-F52D58A4-5537-4D6B-8034-FB89943D63C2 Q30418053-29E0D3FF-F3CC-4C72-9B84-1A796913E7B4 Q33590913-6BF3374F-A6E5-46D7-8D3D-381C20483F61 Q33755396-9CD06491-6998-4487-AB6D-054E50B16CEE Q34032634-8D897EB7-CDC0-4D7B-A248-46E1C4E23F63 Q34220004-730CF629-6A39-4C26-80B2-287401D0F1C2 Q34518522-7302558E-B5E8-4FB7-A6A4-3311938D1F35 Q34565497-71303033-8C5A-46E3-BB3A-9E572086D1DE Q35627332-037C38CD-410B-4C6B-9F9C-EF8496E264A0 Q35685121-25CEC20E-E20C-4965-B834-D31C2C0777E0 Q35712166-31FCD00E-9EBE-4A29-A0D2-44D885150AAF Q35833310-B6E29ECF-221A-4F2E-BE81-B01951C3A58C Q35875805-372F3CC6-86E7-4C22-90DC-0671B8AF0892 Q36100165-7D6B00E6-9134-4D2E-82DA-659155E5C018 Q36740926-9701A2E9-DB8D-403B-ADED-5C7B63FCA27C Q37391143-3A79D363-27C4-4DF6-8F0D-BC36ADCE88F6 Q37705738-06284323-D3BD-4F13-89D8-C50B868CC92E Q37975550-0BA96C67-16AD-45D0-85E9-C6DFA1AB2C86 Q38187892-0E457B94-8195-4C5F-8464-F708B02902CD Q38221823-0D014FEB-4C2C-495F-B8B7-130F75CA5CFA Q38374695-F55F5DF5-1751-4B56-8399-EA29774157A8 Q38732635-92B51E15-A996-4F9A-867A-048D2C48B557 Q38799006-8974575B-643F-4DB8-BCE5-6854075FD8A8 Q38799949-FAF22E7D-992D-4748-9217-B63FDAF3157B Q39017592-3DF3976D-4F5D-43D4-934B-1566853FAF36 Q39478842-325D24D4-5E31-4C8C-8E3B-D6DE0D2E9A62 Q39749601-B491681F-4A19-4A01-89CF-CBD4CF96B1D4 Q40207289-EF3DA954-93F3-44FF-87EA-F2EA9174A9BA Q41522057-37C7536C-9D67-4D95-BDDC-B37479D67BC7 Q42595344-88C7D153-CA80-4193-91DA-F2585C20F086 Q46535632-013AAED4-4DF7-4693-A80E-64F5F90A9270 Q47550500-21A9AB38-E97E-4F84-9167-4BA23DF6A158 Q47586487-B21999E5-5DD7-47BB-B262-2E8C2B5A5C4B Q47741544-1141AB27-DD20-41C8-99DE-94DB33AF144D Q47741604-715EEB9B-4666-4BF3-8551-6A9F1A880505 Q48295452-6DCD721D-2078-46C0-9EA1-9AAFC27EC468 Q53132267-35083928-C719-43B9-81DE-BF98AB1FB99B

P2860

Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder.

http://www.wikidata.org/entity/Q48374137

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Long-term safety and effective ...... ficit/ hyperactivity disorder.

@en

Long-term safety and effective ...... ficit/ hyperactivity disorder.

@nl

type

label

Long-term safety and effective ...... ficit/ hyperactivity disorder.

@en

Long-term safety and effective ...... ficit/ hyperactivity disorder.

@nl

prefLabel

Long-term safety and effective ...... ficit/ hyperactivity disorder.

@en

Long-term safety and effective ...... ficit/ hyperactivity disorder.

@nl

P1433

Q48374137-DFCAB590-7F1F-4C8D-9F3D-686036BE93EB

P1476

Q48374137-CDD2BC1C-3811-4540-8D96-F01637A83327

P2093

Q48374137-07D29BC8-3EDC-431D-A922-C015AB3D1890

Q48374137-0897F1D2-30B2-4ED9-B8AF-1F26E0B7B55E

Q48374137-0B75C86D-9FCC-4FDC-93FD-51851D36A7EA

Q48374137-C05DBAD2-7220-488F-A0F0-1AB90047788B

Q48374137-F7D8107E-D2D9-4FF4-896C-B1F69E54CE88

Q48374137-FCE31B9E-F595-4FFC-9B8B-6F7089F5B709

P2860

Q48374137-0C296730-616C-4F6B-9A21-F95465487574

Q48374137-12C16B22-6A91-49ED-8A23-2E8D8FDAF6C9

Q48374137-22882F5D-D31E-4E1B-B177-47F7D64FF646

Q48374137-249257C3-7DA1-4C2D-A278-9820B98C7FAA

Q48374137-40F6CC3F-61A4-4C6D-9BF9-C729387AF193

Q48374137-43EEEF4B-0CFC-4B5A-9E8B-3983C9EC9B5C

Q48374137-4D3E7865-CE6B-4C02-A491-4C4C0801688D

Q48374137-4E7C28C6-4E9C-4638-978C-D1C5399E4C9F

Q48374137-5328A41A-9AE6-46FC-9552-C7CF9775CE8E

Q48374137-57DC159B-328D-4707-9342-7830D7EF52C7

P304

Q48374137-86FEEC35-F97E-49A5-A9F0-B654A00EFAE5

P31

Q48374137-06E8B502-A9A0-41FE-BD56-FBEFC161A872

P356

Q48374137-DD00BC35-28ED-4D2E-8223-9D73508D76C4

P433

Q48374137-80A82EA2-C549-48F9-9B04-90A006A80B86

P478

Q48374137-6FED5906-0412-442F-9CE2-919C10B62B79

P50

Q48374137-30346896-E23A-4C8F-86BC-D58E5EF28A7B

P577

Q48374137-181FB34D-1E94-4050-BADE-C86BEAE0F8F1

P698

Q48374137-EE408552-8716-4E84-98F0-7AA738075F52

P921

Q48374137-B12840D7-A99C-40AC-ABEC-E5F93A92FCB3

P356

S1092852900024056

P1433

C N S Spectrums

P1476

Long-term safety and effective ...... eficit/ hyperactivity disorder

@en

P2093

304 Study Group

http://www.w3.org/2001/XMLSchema#string

Greg Mattingly

http://www.w3.org/2001/XMLSchema#string

Joel Young

http://www.w3.org/2001/XMLSchema#string

Joseph Gao

http://www.w3.org/2001/XMLSchema#string

Liza Squires

http://www.w3.org/2001/XMLSchema#string

Richard Weisler

http://www.w3.org/2001/XMLSchema#string

P2860

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

The ADHD and sleep conundrum: a review.

Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: a single-dose, crossover pharmacokinetic study.

Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder.

Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care.

Sleep and sleep disorders in adults with attention deficit/hyperactivity disorder.

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.

P304

573-585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S1092852900024056

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20095369

http://www.w3.org/2001/XMLSchema#string

P921